Form 6-K Calliditas Therapeutics For: Jul 19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. CMG
8. KLAC
9. BIIB
10. ETSY

Go back to Form 6-K Calliditas Therapeutics For: Jul 19

Calliditas Therapeutics AB (CALT) Gains on EU Licensing Deal

July 21, 2021 10:26 AM EDT

On July 21st, 2020, Calliditas Therapeutics AB (NASDAQ: CALT) announced that it has entered into a licensing agreement with STADA Arzneimittel AG ("STADA") for EU commercialization of Nefecon CALTs novel drug candidate with the potential to become the first EU approved treatment for Bergers disease.

Under the terms of the agreement, Calliditas is entitled to receive an initial upfront payment of 20M EUR ($24m) upon signing and up to an additional 77.5M EUR ($91m) in future... More